One of the annoyances associated with radiation treatments given over a long duration (for prostate cancer and for other reasons) is a growing feeling of fatigue. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: effect, exercise, fatigue, IMPACT, Management, radiation | 1 Comment »
A group of Finnish researchers have planned a new trial to investigate whether population-based screening for prostate cancer is justifiable if a mortality benefit can be proven with a substantial reduction in rates of over-treatment. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Management, outcome, screening, Treatment, trial | Leave a comment »
The term “over-diagnosis” didn’t exist 15 years ago in the management of prostate cancer. (Well, actually it did, but it would very rarely — if ever — have come to the notice of any patient or even of the average urologist or primary care physician.) … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Management, over-diagnosis, risk | 5 Comments »
Really sound guidance on “the best” way to treat men who are initially diagnosed with lymph node-positive (TxN1M0) prostate cancer — or are found to have such cancer at the time of first-line surgery — is not as readily available as one might like. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: lymph, Management, node, outcome, positive, Treatment | 4 Comments »
The gold standard for the clinical relevance of any new test in the management of a specific disease is … Do the results of the test change the way a physician would previously have managed patients? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gallium-68, Management, PET/CT, PSMA, recurrence, scan | 3 Comments »
Many readers, and particularly many support group leaders and other educators, may want to read and retain a copy of this very recent article in Oncology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, Management, surveillance | 2 Comments »
The abstract of a paper currently in press in the Journal of Urology has offered us some potentially fascinating insight into the comparative outcomes of patients with low- and higher-risk forms of localized prostate cancer when they are initially managed on active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, Management, outcome, risk, surveillance | 4 Comments »
A new article on the HealthNewsReview web site addresses issues related to the diagnosis of prostate cancer and the management of low-risk forms of the disease using active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, journalism, Management, media, risk, surveillance, Wolinsky | Leave a comment »
A new analysis of a large data set compiled by Kaiser Permanente suggests that combining PSA data with genetic risk data may offer a much more effective way to assess risk for clinically significant prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: genomics, gentics, Management, PSA, risk, strategy | 8 Comments »
The population-based rate of Medicare patients getting treatment for prostate cancer dropped by 42 percent from 2007 to 2012 … but this drop did not occur in patients who had a high risk of dying from a cause other than prostate cancer within 10 years, who are arguably among those who least need immediate treatment for prostate cancer (and especially for low-risk forms of prostate cancer). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: change, Diagnosis, Management, Medicare, risk, Treatment | 1 Comment »
As regular readers will be well aware, there are now several different tests available that can be used to assess risk for low- and very low-risk forms of prostate cancer at time of diagnosis (as opposed to clinically significant forms that need early treatment). … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: cost, genetic, genomic, Management, risk, test | 4 Comments »
Earlier this year, in late May and early June, Prostate Cancer International (PCaI) conducted what we have described as a very primitive pilot survey on prostate cancer patients’ perceptions of “value” in the management of this disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: Diagnosis, Management, patient, results, survey, Treatment, value | 5 Comments »
An article with the above title appears to be scheduled for upcoming publication in Scientific American but is already available on line on the Scientific American web site. It may be of interest to a number of our readers. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: genetics, Management, mutation, risk | 4 Comments »
A newly published paper in the journal PLoS Medicine has set out a new set of definitions of five “risk strata” into which we can subdivide men diagnosed with prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: decision-making, Diagnosis, Management, prognosis, risk, strata | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 